1. Generic & Brand Names
Generic: Doxycycline
Brands: Vibramycin®, Oracea® (low-dose acne), Doryx® (delayed-release), Monodox®
Formulations:
Tablets/capsules (20mg, 50mg, 100mg)
Delayed-release tablets (75mg, 100mg, 150mg)
Oral suspension (25mg/5mL)
IV injection (100mg/vial)
2. Drug Class & Mechanism
Class: Tetracycline antibiotic
Mechanism:
Inhibits 30S ribosomal subunit → bacteriostatic
Anti-inflammatory effects (key for acne)
Spectrum:
Respiratory: Mycoplasma, Chlamydia, Legionella
Skin: P. acnes, S. aureus (MSSA)
Other: Rickettsia, Lyme disease, Malaria prophylaxis
3. FDA-Approved Uses
| Condition | Key Applications |
|---|---|
| Acne Vulgaris | Inflammatory acne (≥8 years) |
| Respiratory Infections | Community-acquired pneumonia (CAP), sinusitis, bronchitis |
| Other Uses | Lyme disease, malaria prophylaxis, STIs (chlamydia) |
4. Dosing Regimens
| Indication | Adult Dose | Pediatric Dose (≥8 yrs)* |
|---|---|---|
| Inflammatory Acne | 50-100 mg daily (Oracea®: 40 mg AM) | 0.5-1 mg/kg/day |
| CAP/Sinusitis | 100 mg q12h × 72h → 100 mg daily | 2.2 mg/kg q12h (max 100 mg/dose) |
| Lyme Disease | 100 mg q12h × 14-21 days | 1-2 mg/kg q12h (max 100 mg/dose) |
🚫 Avoid under age 8 (tooth discoloration)
Notes:
Take with full glass of water (minimize esophageal irritation)
Avoid dairy/antacids 2h before/after (chelates Ca²⁺/Mg²⁺)
5. Side Effects
| Common (≥10%) | Serious (<1%) |
|---|---|
| Nausea/vomiting | Photosensitivity (severe sunburns) |
| Esophageal irritation | Intracranial hypertension (headache, vision loss) |
| Diarrhea | Hepatotoxicity (jaundice) |
| Vaginal candidiasis | Stevens-Johnson Syndrome |
| Tooth discoloration (children/fetus) | Esophageal ulceration |
6. Black Box Warnings & Contraindications
🚫 Absolute Contraindications:
Pregnancy (Category D: fetal tooth/bone toxicity)
Children <8 years (permanent tooth discoloration)
Severe hepatic impairment
Critical Warnings:
Photosensitivity: Risk persists 72h post-dose → strict sun avoidance
Avoid with: Isotretinoin (↑ intracranial pressure risk)
7. Drug Interactions
| Medication | Risk | Management |
|---|---|---|
| Antacids/Ca²⁺/Fe²⁺ | ↓ Absorption by 90% | Separate by 2-3 hours |
| Warfarin | ↑ INR → bleeding | Monitor INR weekly |
| Penicillins | Antagonistic effect | Avoid concurrent use |
| Alcohol | ↓ Efficacy + ↑ hepatotoxicity risk | Avoid |
8. Acne-Specific Protocols
Initial Therapy:
100 mg daily × 4-12 weeks
Maintenance:
Reduce to 50 mg daily or Oracea® (40 mg delayed-release)
Adjunct Therapy:
Combine with topical retinoids/benzoyl peroxide
Monitor:
Liver enzymes q6mo for chronic use
9. Respiratory Infection Notes
First-line for:
Atypical pneumonia (Mycoplasma, Chlamydia)
COPD exacerbations with purulent sputum
Not for:
Streptococcal pharyngitis
Viral bronchitis
Resistance Concerns:
S. pneumoniae resistance ~15% (use only if atypical suspected)
10. Storage & Administration
Tablets: Store at 20-25°C; protect from light/moisture
Suspension: Refrigerate; discard after 14 days
IV: Administer over 1-4 hours; avoid sunlight exposure during infusion
Clinical Practice Tips
⚠️ Sun Exposure Warning:
Patients should use SPF 50+, wear hats, avoid UV lights
Photosensitivity rash may resemble sunburn → differentiate from allergy
⚠️ Esophageal Safety:
Never take at bedtime/lying down → risk of ulceration
If nausea: take with non-dairy food (e.g., apple sauce)
✅ Acne Advantages:
Anti-inflammatory effect reduces papules/pustules faster than antibiotics alone
Oracea® (40 mg) minimizes resistance risk
❌ Avoid in Pregnancy:
Permanent yellow-gray tooth discoloration in fetus
Alternative acne agents: Azelaic acid, Erythromycin topicals
Doxycycline vs. Other Acne Antibiotics
| Parameter | Doxycycline | Minocycline | Erythromycin |
|---|---|---|---|
| Acne Efficacy | +++ | ++++ | ++ |
| Photosensitivity | Severe | Moderate | Minimal |
| CNS Effects | Rare | Vertigo (15-30%) | Rare |
| Cost | $ | $$$ | $$ |
💡 Pro Tip: For acne, use sub-antimicrobial doses (e.g., Oracea® 40 mg) to reduce resistance while maintaining anti-inflammatory benefits.
Prescribing Status: Widely available; monitor for resistance development with long-term use.
Comments
Post a Comment